Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 From the Food and Drug Administration.

× No keyword cloud information.

5 in total

1. A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia.

Authors: Nitin Jain; William Wierda; Alessandra Ferrajoli; Franklin Wong; Susan Lerner; Michael Keating; Susan O'Brien
Journal: Cancer Date: 2009-10-01 Impact factor: 6.860

2. Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

Authors: Byung Woog Kang; Won Seog Kim; Chul Kim; Geundoo Jang; Sung Sook Lee; Yoon Hee Choi; Dae Ho Lee; Sang We Kim; Shin Kim; Jin-Sook Ryu; Jooryung Huh; Jung Shin Lee; Cheolwon Suh
Journal: Invest New Drugs Date: 2009-06-23 Impact factor: 3.850

Review 3. Benefits and risks of simvastatin in patients with familial hypercholesterolaemia.

Authors: Pedro Mata; Rodrigo Alonso; Juan Badimón
Journal: Drug Saf Date: 2003 Impact factor: 5.606

4. Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome.

Authors: Angela John Thurman; Laura A Potter; Kyoungmi Kim; Flora Tassone; Amy Banasik; Sarah Nelson Potter; Lauren Bullard; Vivian Nguyen; Andrea McDuffie; Randi Hagerman; Leonard Abbeduto
Journal: J Neurodev Disord Date: 2020-04-22 Impact factor: 4.025

Review 5. Targeted Radionuclide Therapy: Practical Applications and Future Prospects.

Authors: Katherine Zukotynski; Hossein Jadvar; Jacek Capala; Frederic Fahey
Journal: Biomark Cancer Date: 2016-05-18

5 in total